By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Announces First-Half 2016 Financial Results and Provides Strategy Update 9/27/2016 1:48:00 PM
TxCell To Publish Results For The First Half Of 2016 And To Provide Strategy Update On Tuesday, September 27, 2016 9/21/2016 10:01:30 AM
TxCell To Present At The 18th Annual Rodman & Renshaw Global Investment Conference On September 13, 2016 9/6/2016 4:07:23 PM
TxCell Appoints Biogen (BIIB)’s Dr. Olivier Danos, Pioneer In Gene Therapy For Neurological Disorders, To Its Scientific Advisory Board 8/24/2016 1:35:36 PM
TxCell Announces The Effective Implementation Of The Convertible Notes With Warrants (OCABSA) Financing And The Issue Of A First Tranche For An Amount Of EUR 3 Million In Nominal Value 8/3/2016 10:58:26 AM
TxCell: Financial Information For The 2nd Quarter Of 2016 7/27/2016 12:15:41 PM
TxCell Exercises Option From Weizmann Institute of Science Following Effective Grant Of Broad CAR-Treg Patent In Europe 6/22/2016 8:04:48 AM
TxCell Implements A New Financing Contract Of Up To EUR 20 Million In Nominal Value Through Convertible Notes With Warrants (OCABSA) 6/17/2016 1:52:02 PM
TxCell To Chair World’s First Workshop Dedicated To Adoptive T Cell Therapy With Regulatory T Cells 6/14/2016 12:43:56 PM
TxCell And The Lübeck Institute Of Experimental Dermatology Launch Collaboration To Develop CAR-Tregs In Bullous Pemphigoid 6/2/2016 1:40:11 PM